ID
EN
Website ini sudah didukung oleh fitur aksesibilitas. Silahkan aktifkan fitur microsoft narator / android talkback / mac dan ios voiceover di perangkat anda.
Our Strategy
Now is the time for Bio Farma to make changes for the better towards globally competitive biotechnology innovation by implementing the 2017-2021 corporate strategy.
01
Corporate Plan & Business Development Strategy
Business development and corporate planning strategy was aimed tointensify R&D activities to improve our product portfolio.
02
Human Capital & Innovation Strategy
Human capital and innovation strategy was aimed to develop various levels of the company, from process, product, to research to encourage tangible internal developments for our external shareholders.
03
Manufacture & Supply Chain Strategy
The main aim of the strategy was aimed to improve capacity by procuring production machinery, particularly for the fill & finish process. By taking advantage of information technology and ERP systems, we were able to improve our supply chain process to ensure the readiness of raw materials and thus ensure that vaccine production was on target and able to meet national and global demands.
04
Investment & Asset Management Strategy
Investment and asset management strategy was aimed to improve capacity and diversify our product portfolio by investing in new production infrastructure and land. Land for facilities was procured with regard to the environment.
05
Financial Support Strategy
Our financial strategy was supported by an integrated IT system at every level of the company.
Stategi
Kemitraan
Kemitraan
Strategi
Pengembangan
Bisnis
Pengembangan
Bisnis
Kini saatnya Bio Farma melakukan perubahan ke arah yang lebih baik menuju inovasi bioteknologi berdaya saing global dengan menyusun strategi 2017 - 2021
Stategi
Keuangan
Keuangan
Strategi
Produk
Produk